Distribution of gold in blood following administration of auranofin (SK&F D-39162)
- PMID: 114638
Item in Clipboard
Distribution of gold in blood following administration of auranofin (SK&F D-39162)
J Rheumatol Suppl.
1979.
Abstract
After oral administration of auranofin (SK&F D-39162), a new antiarthritic gold compound, to rats, dogs and humans, a major portion (approximately 50%) of the blood gold content was found to be associated with cellular components. This property is in marked contrast to that reported for gold sodium thiomalate and represents another of the many physical, chemical and pharmacological differences between these therapeutic gold compounds. Although the clinical significance of this property is not presently known, it is recommended that pharmacokinetic studies involving auranofin include the assessment of both blood and serum gold levels.
Similar articles
-
Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.J Pharmacol Exp Ther. 1976 Apr;197(1):142-52. J Pharmacol Exp Ther. 1976. PMID: 772185
-
Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.J Rheumatol. 1980 Nov-Dec;7(6):820-4. J Rheumatol. 1980. PMID: 6782245
-
Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.J Rheumatol. 1983 Feb;10(1):117-20. J Rheumatol. 1983. PMID: 6405031
-
Auranofin.Clin Rheum Dis. 1984 Aug;10(2):369-83. Clin Rheum Dis. 1984. PMID: 6239742 Review.
-
[The pharmacology of gold compounds].Wien Klin Wochenschr Suppl. 1984;156:7-13. Wien Klin Wochenschr Suppl. 1984. PMID: 6442062 Review. German.
Cited by
-
A comparison of the effects of two gold-containing therapeutic agents on articular chondrocyte growth in vitro.Rheumatol Int. 1983;3(2):49-56. doi: 10.1007/BF00541144. Rheumatol Int. 1983. PMID: 6414070
-
Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.Drugs. 1984 May;27(5):378-424. doi: 10.2165/00003495-198427050-00002. Drugs. 1984. PMID: 6426923 Review.
-
Clinical pharmacokinetics of oral and injectable gold compounds.Clin Pharmacokinet. 1986 Mar-Apr;11(2):133-43. doi: 10.2165/00003088-198611020-00003. Clin Pharmacokinet. 1986. PMID: 3082559 Review.
-
Effect of auranofin on antibody-dependent cellular cytotoxicity (ADCC) mediated by rat peripheral blood polymorphonuclear leukocytes and mononuclear cells.Inflammation. 1980 Sep;4(3):279-88. doi: 10.1007/BF00915029. Inflammation. 1980. PMID: 6776048
-
Disease-modifying antirheumatic drugs. Potential effects in older patients.Drugs Aging. 1995 Dec;7(6):420-37. doi: 10.2165/00002512-199507060-00003. Drugs Aging. 1995. PMID: 8601050 Review.